HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen
NCT02776202
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
15
Enrollment
OTHER_GOV
Sponsor class
Conditions
Sickle Cell Disease
Interventions
DRUG:
Fludarabine monophosphate
Sponsor
National Guard Health Affairs